Initially discovered in Drosophila, the Hippo (Hpo) pathway has been recognized as a conserved signaling pathway that controls organ size during development by restricting cell growth and proliferation and by promoting apoptosis. In addition, abnormal activities of several Hpo pathway components have been implicated in human cancer. Here, we review the current understanding of the molecular and cellular basis of Hpo signaling in development and tumorigenesis, and discuss how the Hpo pathway integrates spatial and temporal signals to control tissue growth and organ size.Different organs exhibit characteristic size, which is determined by the number and size of their constituent cells. 1 How the organ size is controlled during animal development has been a fascinating problem in modern biology. The control of organ size depends on a delicate balance of cell proliferation and cell death, which are properly coordinated in response to both global and local stimuli. Although tissue growth is influenced by environmental factors such as hormonal signals and nutrients, organ-intrinsic mechanisms also play important roles. By genetic screens for, and characterization of, mutations that cause tissue overgrowth in Drosophila, several signaling pathways, including the Hpo pathway, have been unraveled as organ-intrinsic mechanisms that control organ size. 2
Finding Hippo-An Emerging Size Control PathwayThe imaginal discs of Drosophila, which give rise to adult structures such as wings, legs and eyes, provide an attractive system to study size control. 3 Imaginal discs are specified during embryonic development but growth occurs at larval stages during which the number of cells of each disc increases exponentially. For example, a wing disc has less than 50 cells at the beginning of first instar; however, it contains over 50,000 cells at the end of third instar. Imaginal discs appear to possess intrinsic mechanisms to determine their final size and defects in these mechanisms result in overgrowth in a disc autonomous fashion. 4,5 In the past, tumor suppressor mutants were identified by genetic screens for mutations that either result in enlarged imaginal discs in homozygous late third instar larvae, or cause overgrowth of imaginal disc derivatives in mosaic flies that carry clones of homozygous mutant cells in an otherwise heterozygous background (Fig. 1). 2,6 In particular, genetic mosaic screens have led to the identification of a number of tumor suppressor genes, including warts/ large tumor suppressor (wts/lats), 7,8 salvador (sav) 9 and hpo/dMST, 10-14 which fall into an emerging tumor suppressor pathway, the so-called Hpo pathway (Fig. 2).Central to the Hpo pathway is a kinase cascade consisting of four proteins including Hpo, Sav, Wts and Mats (Fig. 2). Hpo is the Drosophila homolog of mammalian Ste20 family kinases MST1 and MST2, and forms a complex with the WW-repeat scaffolding protein Sav to phosphorylate and activate the downstream kinase Wts, a member of the Nuclear Dbf-2-related (NDR) kinase family. 7-14 Wts acts ...